GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1) (N-Term) Peptide
Quick Overview for GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1) (N-Term) Peptide (ABIN8101222)
Target
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- GABARAPL1 Peptide - N-terminal region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-GABARAPL1 antibody ( ARP55398_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- GABARAPL1 (GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1))
-
Background
-
Background Information: GABARAPL1 increases cell-surface expression of kappa-type opioid receptor through facilitating anterograde intracellular trafficking of the receptor.
Alternative Symbols: APG8L, ATG8, ATG8L, GEC1, ATG8B, APG8-LIKE
-
Molecular Weight
- 14kDa
-
Gene ID
- 23710
-
NCBI Accession
- NP_113600
-
UniProt
- Q9H0R8
Target
-